SCHEMBL3862068

SCHEMBL3862068

COP(=O)(OC[C@H]1O[C@@H](n2cnc3c(S)ncnc32)C(O)C1O)OP(=O)(O)OP(=O)(O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX3 P56373 6/20 0.61
P2RY1 P47900 5/20 0.61
P2RX2 Q9UBL9 5/20 0.61
P2RY2 P41231 4/20 0.61
P2RX1 P51575 3/20 0.61
SRC P12931 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
P2RX4 Q99571 2/20 0.61
ALDH1A1 P00352 1/20 0.61
ADORA1 P30542 2/20 0.60
TRPM2 O94759 2/20 0.60
DNPH1 O43598 1/20 0.60
PRKAB2 O43741 1/20 0.60
LDHA P00338 1/20 0.60
ADRB2 P07550 1/20 0.60
FBP1 P09467 1/20 0.60
PRKAG1 P54619 1/20 0.60
PRKAA2 P54646 1/20 0.60
PDE4D Q08499 1/20 0.60
KCNH2 Q12809 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3858337 0.96 P2RY1 (0.62) P2RX3P2RY1P2RX2P2RY2P2RX1
SCHEMBL1905818 0.91 P2RX3 (0.72) P2RX3P2RY1P2RX2P2RY2P2RX1
SCHEMBL1905822 0.91 P2RX3 (0.72) P2RX3P2RY1P2RX2P2RY2P2RX1
SCHEMBL1906291 0.90 P2RY1 (0.74) P2RX3P2RY1P2RX2P2RY2P2RX1
SCHEMBL1906288 0.90 P2RY1 (0.74) P2RX3P2RY1P2RX2P2RY2P2RX1
SCHEMBL29015761 0.90 P2RY1 (0.77) P2RX3P2RY1P2RX2P2RY2P2RX1
SCHEMBL3859612 0.89 P2RY1 (0.67) P2RX3P2RY1P2RX2P2RY2P2RX1
SCHEMBL14853709 0.88 P2RY1 (0.59) P2RX3P2RY1P2RX2P2RY2P2RX1
SCHEMBL15084467 0.88 ADORA1 (0.67) P2RX3P2RY1P2RX2P2RY2P2RX1
Thioinosine Monophosphate SCHEMBL379366 0.87 DNPH1 (0.77) P2RX3P2RY1P2RX2P2RY2P2RX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1825254-A4 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY PROMETHEUS LAB INC (US) 2009-01-14 EP disclosed
EP-1825254-A2 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY Prometheus Laboratories, Inc. (US) 2007-08-29 EP disclosed
US-20060216726-A1 Method for optimizing thiopurine efficacy and toxicity using mass spectrometry PROMETHEUS LABORATORIES INC. (US) 2006-09-28 US disclosed
WO-2006055527-A2 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY PROMETHEUS LABORATORIES INC. (US) 2006-05-26 WO disclosed